Study guide

10.1 Acute Kidney Injury & Chronic Kidney Disease

USMLE Step 2 CK Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Human Development & Well-Patient Care

1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening

2 Chapter 2: Immune System & Immunologic Disorders

2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles

3 Chapter 3: Blood & Lymphoreticular System

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders

4 Chapter 4: Behavioral Health & Psychiatric Disorders

4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology

5 Chapter 5: Nervous System & Special Senses

5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies

6 Chapter 6: Musculoskeletal System & Dermatology

6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders

7 Chapter 7: Cardiovascular System

7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease

8 Chapter 8: Respiratory System

8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases

9 Chapter 9: Gastrointestinal System

9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis

10 Chapter 10: Renal, Urinary & Reproductive Systems

10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease

11 Chapter 11: Pregnancy, Childbirth & Puerperium

11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management

12 Chapter 12: Endocrine System

12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology

13 Chapter 13: Multisystem Processes & Critical Care

13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens

14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation

14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine

15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice

15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions

10.1 Acute Kidney Injury & Chronic Kidney Disease

Key Takeaways Explain This Topic AI

Acute Kidney Injury (AKI) is defined by KDIGO criteria as an increase in serum creatinine by >=0.3 mg/dL within 48 hours, >=1.5 times baseline within 7 days, or urine volume <0.5 mL/kg/h for 6 consecutive hours.

Prerenal AKI features a BUN/Cr ratio >20:1, Fractional Excretion of Sodium (FENa) <1% (or FEUrea <35% in patients taking diuretics), and urine osmolality >500 mOsm/kg.

Intrinsic AKI (e.g., Acute Tubular Necrosis [ATN]) demonstrates a BUN/Cr ratio <15:1, FENa >2%, urine sodium >40 mEq/L, urine osmolality <350 mOsm/kg, and muddy brown granular casts.

Chronic Kidney Disease (CKD) diagnosis requires persistent evidence of kidney damage or GFR <60 mL/min/1.73 m² for at least 3 months, with Stage 5 CKD (End-Stage Renal Disease) defined as GFR <15 mL/min/1.73 m².

High-yield urgent indications for hemodialysis are remembered by the mnemonic AEIOU: Acidosis (pH <7.1 refractory), Electrolytes (hyperkalemia >6.5 mEq/L or with ECG changes), Ingestions (Salicylates, Lithium, Isopropanol, Methanol, Ethylene glycol), Overload (volume refractory to diuretics), and Uremia (pericarditis, encephalopathy, or neuropathy).

Last updated: July 2026

Acute Kidney Injury Definitions & Classification

Acute Kidney Injury (AKI) represents an abrupt decline in renal function occurring over hours to days, leading to the accumulation of nitrogenous waste products (azotemia) and perturbations in fluid, electrolyte, and acid-base homeostasis. On the USMLE Step 2 CK, diagnostic evaluation begins by categorizing AKI according to standardized consensus definitions and hemodynamic pathophysiology.

KDIGO Diagnostic Criteria

According to the KDIGO (Kidney Disease: Improving Global Outcomes) guidelines, AKI is formally diagnosed when a patient meets any one of the following three objective criteria:

An increase in serum creatinine by >=0.3 mg/dL (>=26.5 umol/L) within 48 hours.

An increase in serum creatinine to >=1.5 times baseline , which is known or presumed to have occurred within the prior 7 days.

  • Urine volume <0.5 mL/kg/h for 6 consecutive hours . [ Suspected Acute Kidney Injury ]
  • |
  • [ Step 1: Renal Ultrasound ]
  • |
  • +--------------------------+--------------------------+
  • | |
  • [ Hydronephrosis / Obstruction ] [ No Obstruction ]
  • | |
  • (Postrenal AKI) |
  • > Foley Catheter / [ Step 2: Urine Spot ]
  • Nephrostomy Tube (FENa / FEUrea / Osm)
  • |
  • +-------------------------------------+-------------------------------------+
  • | |
  • [ FENa <1% / FEUrea <35% ] [ FENa >2% / FEUrea >50% ]
  • [ Urine Osm >500 mOsm/kg ] [ Urine Osm <350 mOsm/kg ]
  • | |
  • (Prerenal AKI) (Intrinsic AKI)
  • > Fluid Bolus / Restor Perfusion -> Identify Parenchymal Etiology
  • (ATN vs AIN vs Glomerulonephritis)
  • Diagnostic Differentiation: Prerenal, Intrinsic & Postrenal AKI

Determining the etiology of AKI requires evaluating urine chemistry, urine osmolality, and microscopic urinalysis. The table below outlines the classic laboratory findings used to distinguish prerenal hypoperfusion from intrinsic renal parenchymal damage.

  • Diagnostic Parameter Prerenal Azotemia Intrinsic AKI (Acute Tubular Necrosis) Postrenal Obstruction
  • BUN / Serum Creatinine Ratio >20:1 <15:1 Variable (>20:1 early, <15:1 late)
  • Fractional Excretion of Na (FENa) <1% >2% >2% (late stage)
  • Fractional Excretion of Urea (FEUrea) <35% (use if patient takes diuretics) >50% >50%
  • Urine Sodium Concentration <20 mEq/L >40 mEq/L >40 mEq/L
  • Urine Osmolality >500 mOsm/kg <350 mOsm/kg <350 mOsm/kg
  • Urinary Sediment Hyaline casts or normal Muddy brown granular casts, tubular cells Normal, RBCs, or crystals
  • Prerenal Azotemia

Prerenal AKI results from compromised renal perfusion without structural renal parenchymal injury. Common etiologies include intravascular volume depletion (hemorrhage, gastrointestinal fluid loss, excessive diuresis), effective arterial volume depletion (systolic heart failure, decompensated cirrhosis), and intrarenal hemodynamics altered by medications ( ACE inhibitors/ARBs dilate efferent arterioles; NSAIDs constrict afferent arterioles). The renal tubules remain functionally intact, appropriately reabsorbing sodium and water to expand intravascular volume, yielding low FENa (<1%) and concentrated urine (>500 mOsm/kg).

Intrinsic Renal Parenchymal Disease

Intrinsic AKI involves structural damage to glomeruli, tubules, interstitium, or renal vasculature. Acute Tubular Necrosis (ATN) accounts for over 85% of intrinsic AKI cases in hospitalized patients. ATN stems from either prolonged ischemic injury (unresolved prerenal state, septic shock) or direct nephrotoxic exposure:

Exogenous Nephrotoxins : Aminoglycosides (gentamicin), radiocontrast agents, cisplatin, amphotericin B, and vancomycin.

Endogenous Nephrotoxins : Myoglobin (rhabdomyolysis following crush injury or prolonged immobilization), hemoglobin (hemolysis), and uric acid/light chains (tumor lysis syndrome or multiple myeloma).

Pathologically, necrotic tubular epithelial cells slough off into the tubular lumen, forming diagnostic muddy brown granular casts on urine microscopy.

Postrenal Urinary Tract Obstruction

Postrenal AKI occurs when urinary outflow is acutely obstructed bilaterally (or unilaterally in a patient with a single functioning kidney). Causes include benign prostatic hyperplasia (BPH), prostate cancer, bilateral nephrolithiasis, neurogenic bladder, or retroperitoneal fibrosis. Renal ultrasound is the diagnostic procedure of choice to visualize hydronephrosis and urinary bladder distension. Immediate bladder catheterization or percutaneous nephrostomy tube placement is therapeutic.

Chronic Kidney Disease (CKD) & Complications

Chronic Kidney Disease (CKD) is defined as abnormalities of kidney structure or function present for >=3 months , with implications for health. It is staged primarily by Estimated Glomerular Filtration Rate (eGFR) :

Stage 1 : eGFR >=90 mL/min/1.73 m² with persistent proteinuria/kidney damage.

Stage 2 : eGFR 60–89 mL/min/1.73 m².

Stage 3a/3b : eGFR 45–59 (3a) and 30–44 (3b) mL/min/1.73 m².

Stage 4 : eGFR 15–29 mL/min/1.73 m² (severely decreased; prepare for vascular access/dialysis).

Stage 5 (ESRD) : eGFR <15 mL/min/1.73 m² (end-stage renal disease requiring renal replacement therapy).

Major Systemic Complications of CKD

Normocytic Normochromic Anemia : Decreased erythropoietin production by renal peritubular interstitial cells. Treatment involves erythropoiesis-stimulating agents (ESAs) like epoetin alfa, provided serum ferritin (>100 ng/mL) and transferrin saturation (>20%) confirm adequate iron stores.

CKD-Mineral and Bone Disorder (CKD-MBD) : Failing kidneys decrease phosphate excretion (hyperphosphatemia) and produce less active 1,25-dihydroxyvitamin D (calcitriol) due to loss of 1-alpha-hydroxylase. Low calcitriol causes hypocalcemia. Combined hyperphosphatemia and hypocalcemia stimulate parathyroid hormone secretion ( secondary hyperparathyroidism ), leading to high-turnover bone disease ( osteitis fibrosa cystica ). Treatment includes dietary phosphate restriction, oral phosphate binders (sevelamer, calcium acetate), and active vitamin D analogs.

Calciphylaxis (Calcific Uremic Arteriolopathy) : Painful, necrotic skin ulcers caused by vascular calcification and thrombosis in patients with advanced ESRD and severe hyperphosphatemia.

Uremic Platelet Dysfunction : Accumulated uremic toxins impair platelet adhesion and aggregation, causing mucosal bleeding and prolonged bleeding time with normal platelet count, PT, and PTT. First-line therapy for acute bleeding is desmopressin (DDAVP) .

Indications for Urgent Hemodialysis

When medical management fails in patients with acute or chronic renal failure, urgent renal replacement therapy (hemodialysis) is indicated. High-yield emergency indications are recalled using the classic AEIOU mnemonic:

A (Acidosis) : Refractory metabolic acidosis with pH <7.1 despite sodium bicarbonate therapy.

E (Electrolytes) : Severe hyperkalemia ( K+ >6.5 mEq/L ) or hyperkalemia with ECG changes refractory to medical stabilization.

I (Ingestions) : Toxic exposures to dialyzable drugs ( SLIME : Salicylates, Lithium, Isopropanol, Methanol, Ethylene glycol).

O (Overload) : Refractory volume overload / pulmonary edema unresponsive to intravenous loop diuretics.

U (Uremia) : Symptomatic uremia, specifically uremic pericarditis (pericardial friction rub), uremic encephalopathy (asterixis, altered mental status), or uremic neuropathy.